Doctor profile · Federal record

Dr. Brian Ward, MD

Gastroenterology Physician (CMS: Gastroenterology) · Internal Medicine Physician · Omaha, NE

  • NPI 1366494643
  • Accepts Medicare
  • 24 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8901 Indian Hills Dr, Suite 200
Omaha, NE 681144057
(402) 397-7057
fax (402) 397-6656

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
December 8, 2009
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RG0100X — NUCC code
State license (1)
Nebraska #23353
Medicaid
NE #47077295213

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1366494643. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
11,068
Distinct HCPCS
10
Medicare allowed
$347,805
HCPCS Description Services Patients Avg allowed
J3380 Injection, vedolizumab, 1 mg 7,800 24 $22
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,360 27 $33
45380 Biopsy of large bowel using a flexible endoscope 168 168 $114
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare 106 106 $228
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope 104 101 $96
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 87 52 $73
99213 Established patient office or other outpatient visit, 20-29 minutes 83 71 $83
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes 55 55 $120
36415 Insertion of needle into vein for collection of blood sample 46 32 $8
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope 46 43 $89

In context: peer comparison

Among 25 peers in Omaha Gastroenterology Physician, average services per provider: 429. This provider delivers 26× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,775
Transactions
62
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Aimmune Therapeutics, INC. 4 $657.10
Gilead Sciences, INC. 8 $146.32
Abbvie INC. 9 $142.70
Janssen Biotech, INC. 11 $137.50
Takeda Pharmaceuticals U.S.A., INC. 5 $111.43
Lilly USA, LLC 4 $99.51
Genzyme Corporation 4 $97.66
Madrigal Pharmaceuticals 5 $96.87
Regeneron Healthcare Solutions, INC. 3 $71.55
Ironwood Pharmaceuticals, INC 3 $67.58
Qol Medical, LLC 2 $45.17
Ipsen Biopharmaceuticals, INC 1 $24.32
Celgene Corporation 1 $17.37
Merck Sharp & Dohme LLC 1 $16.66
Salix Pharmaceuticals, A Division of Bausch Health US, LLC 1 $15.57

By nature of payment

Food and Beverage
$1,775

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
853
Patients
321
Total drug cost
$780,850
Drug Type Claims Patients Total cost
Omeprazole Generic 188 68 $3,322
Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg) Brand 175 168 $4,219
Pantoprazole Sodium Generic 81 28 $1,717
Dicyclomine Hcl Generic 64 21 $1,960
Colestipol Hcl Generic 44 0 $3,452
Famotidine Generic 42 13 $949
Mesalamine Generic 39 0 $19,801
Ursodiol Generic 38 12 $9,522
Trulance (Plecanatide) Brand 37 0 $27,457
Linzess (Linaclotide) Brand 32 0 $25,291

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Brian Ward's medical specialty?
Dr. Brian Ward practices Gastroenterology Physician in Omaha, NE.
Where does Dr. Brian Ward practice?
Dr. Brian Ward practices at 8901 Indian Hills Dr, Omaha, NE 681144057. Office phone: 4023977057.
What is Dr. Brian Ward's NPI?
Dr. Brian Ward's National Provider Identifier (NPI) is 1366494643, issued by NPPES.
Does Dr. Brian Ward accept Medicare assignment?
Yes. Dr. Brian Ward accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brian Ward commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Biopsy of large bowel using a flexible endoscope (HCPCS 45380). Source: CMS Medicare Physician & Other Practitioners file.